First-in-human study and clinical case reports of the alveolar bone regeneration with the secretome from human mesenchymal stem cells

Head and Face Medicine

Volumn 12, Issue 1, 2016, Pages

  Katagiri, Wataru ^a   Osugi, Masashi ^a   Kawai, Takamasa ^a   Hibi, Hideharu ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bone; Mesenchymal stem cells (MSC); Regenerative medicine; Secretome; Tissue engineering

Indexed keywords

ARTIFICIAL MEMBRANE; TOOTH IMPLANT;

AGED; ALVEOLAR BONE; ALVEOLAR RIDGE AUGMENTATION; ARTIFICIAL MEMBRANE; BIOPSY; BONE REGENERATION; CELL CULTURE; COMPLICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; JAW, EDENTULOUS, PARTIALLY; MALE; MIDDLE AGED; PANORAMIC RADIOGRAPHY; PATHOLOGY; PATIENT SELECTION; PERIODONTITIS; PROCEDURES; SURGICAL FLAPS; TISSUE REGENERATION; TISSUE SCAFFOLD; TOOTH IMPLANT; TOOTH IMPLANTATION; TREATMENT OUTCOME; X-RAY COMPUTED TOMOGRAPHY;

AGED; ALVEOLAR PROCESS; ALVEOLAR RIDGE AUGMENTATION; BIOPSY; BONE REGENERATION; CELLS, CULTURED; DENTAL IMPLANTATION, ENDOSSEOUS; DENTAL IMPLANTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GUIDED TISSUE REGENERATION; HUMANS; JAW, EDENTULOUS, PARTIALLY; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; PATIENT SELECTION; PERIODONTITIS; RADIOGRAPHY, PANORAMIC; SURGICAL FLAPS; TISSUE SCAFFOLDS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84954242210     PISSN: None     EISSN: 1746160X     Source Type: Journal    
DOI: 10.1186/s13005-016-0101-5     Document Type: Article

References (40)

1. Arrington ED, Smith WJ, Chambers HG, Bucknell AL, Davino NA. Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res. 1996;329:300-9.
2. Joshi A, Kostakis GC. An investigation of post-operative morbidity following iliac crest graft harvesting. Br Dent J. 2004;196:167-71.
3. Damien CJ, Parsons JR. Bone graft and bone graft substitutes: a review of current technology and applications. J Appl Biomater. 1991;2:187-208.
4. Herford AS, Boyne PJ. Reconstruction of mandibular continuity defects with bone morphogenic protein-2 (rhBMP-2). J Oral Maxillofac Surg. 2008;66:616-24.
5. Woo EJ. Adverse events reported after the use of recomninant human bone morphogenetic protein 2. J Oral Maxillofac Surg. 2012;70:765-7.
6. Perri B, Cooper M, Lauryssen C, Anand N. Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion: a case study. Spine J. 2007;7:235-9.
7. Vaidya R, Carp J, Sethi A, Bartol S, Craig J, Les CM. Complications of anterior cervical discectomy and fusion using recombinant human bone morphogenetic protein-2. Eur Spine J. 2007;16:1257-65.
8. Kawasaki K, Aihara M, Honmo J, Sakurai S, Fujimaki Y, Sakamoto K, et al. Effects of reconmbinant human bone morphogenetic protein-2 on differentiation of cells isolated from human bone, muscle, and skin. Bone. 1998;23:223-31.
9. Langer R, Vacanti JP. Tissue engineering. Science. 1993;260:920-6.
10. Yamada Y, Ueda M, Naiki T, Takahashi M, Hata K, Nagasaka T. Autogenous injectable bone for regeneration with mesenchymal stem cells (MSCs) and platelet-rich plasma (PRP) - Tissue-engineered bone regeneration. Tissue Eng. 2004;10:955-64.
11. Yamada Y, Nakamura S, Ito K, Umemura E, Hara K, Nagasaka T, et al. Injectable bonetissue engineeringusingexpanded mesenchymal stem cells. Stem Cells. 2013;31:572-80.
12. Muller-Ehmsen J, Whittaker P, Kloner RA, Dow JS, Sakoda T, Long TI, et al. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol. 2002;34:107-16.
13. Toma C, Wagner WR, Bowry S, Schwartz A, Villanueva F. Fate of culture-expanded mesenchymal stem cells in the microvasculature: in vivo observations of cell kinetics. Circ Res. 2009;104:398-402.
14. Ide C, Nakai Y, Nakano N, Seo T, Yamada Y, Endo K, et al. Bone marrow stromal cell transplantation for treatment of sub-acute spinal cord injury in rat. Brain Res. 2010;1332:32-47.
15. Chen L, Tredget EE, Wu PYG, Wu Y. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One. 2008;3:e1886.
16. Ciapetti G, Granchi D, Baldini N. The combined use of mesenchymal stromal cells and scaf- folds for bone repair. Curr Pharm Des. 2012;18:1796-820.
17. Baglio SL, Pegtel DM, Baldini N. Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy. Front Physiol. 2012;3:1-11.
18. Katagiri W, Osugi M, Kawai T, Ueda M. Novel cell-free regenerative medicine of bone using stem cell derived factors. Int J Oral Maxillofac Implants. 2013;28:1009-16.
19. Osugi M, Katagiri W, Yoshimi R, Inukai T, Hibi H, Ueda M. Conditioned media from mesenchymal stem cells enhancedbone regeneration in rat calvarial bone defects. Tissue Eng Part A. 2012;18:14779-1489.
20. Inukai T, Katagiri W, Yoshimi R, Osugi M, Kawai T, Hibi H, et al. Novel application of stem cell-derived factors for periodontal regeneration. Biochem Biophys Res Commun. 2013;430:763-8.
21. Kawai T, Katagiri W, Osugi M, Sugimura Y, Hibi H, Ueda M. Secretomes from bone marrow-derived mesenchymal stromal cells enhance periodontal tissue regeneration. Cytotherapy. 2015;17:369-81.
22. Tatum H. Maxillary and sinus implant reconstructions. Dent Clin North Am. 1986;30:207-29.
23. Okuda K, Yamamiya K, Kawase T, Mizuno H, Ueda M, Yoshie H. Treatment of human infrabony periodontal defects by grafting human cultured periosteum sheets combined with platelet-rich plasma and porus hydroxyapatite granules: case series. J Int Acad Periodontol. 2009;11:206-13.
24. Freyman T, Polin G, Osman H, Crary J, Lu M, Cheng L, et al. A quantitative, randomized study evaluating three methods of mes- enchymal stem cell delivery fol- lowing myocardial infarction. Eur Heart J. 2006;27:1114-22.
25. Parekkadan B, van Poll D, Suganuma K, Carter EA, Berthiaume F, Tilles AW, et al. Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS One. 2007;2:e941.
26. Lee JK, Jin HK, Endo S, Schuchman EH, Carter JE, Bae JS. Intracerebral trans- plantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and res- cues memory deficits in Alzheimer's disease mice by modulation of immune responses. Stem Cells. 2010;28:329-43.
27. Cornish J, Grey A, Callon KE, Naot D, Hill BL, Lin CQ, et al. Shared pathways of osteoblast mitogenesis induced by amylin, adrenomedullin, and IGF-1. Biochem Biophys Res Commun. 2004;318:240-6.
28. Li Y, Yu X, Lin S, Li X, Zhang S, Song YH. Insulin-like growth factor 1 enhances the migratory capacity of mesenchymal stem cells. Biochem Biophys Res Commun. 2007;356:780-4.
29. Han X, Amar S. Role of insulin-like growth factor-1 signaling in dental fibroblast apoptosis. J Periodontol. 2003;74:1176-82.
30. Kaiglar D, Krebsbach PH, West ER, Horger K, Huang YC, Mooney DJ. Endothelial cell modulation of bone marrow stromal cell osteogenic potential. FASEB J. 2005;19:665-7.
31. Bostrom MP, Asnis P. Transforming growth factor beta in fracture repair. Clin Orthop Relat Res. 1998;355:S124-131.
32. Fujita T, Shiba H, van Dyke TE, Kurihara H. Differential effects of growth factors and cytokines on the synthesis of SPARC, DNA, fibronectin and alkaline phosphatase activity in human periodontal ligament cells. Cell Biol Int. 2004;28:281-6.
33. Gao J, Symons AL, Bartold PM. Expression of transforming growth factor-beta 1 (TGF-beta1) in the developing periodontium of rats. J Dent Res. 1998;77:1708-16.
34. Morishita R, Nakamura S, Hayashi S, Taniyama Y, Moriguchi A, Nagono T, et al. Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertension. 1999;33:1379-84.
35. Ozaki Y, Nishimura M, Sekiya K, Suehiro F, Kanawa M, Nikawa H, et al. Comprehensive analysis of chemotactic factors for bone marrow mesenchymal stem cells. Stem Cells Dev. 2007;16:119-29.
36. Chen L, Jiang W, Huang J, He B, Zuo G, Zhang W, et al. Insulin-like growth factor 2 (IGF-2) potentiates BMP-9-induced osteogenic differentiation and bone formation. J Bone Miner Res. 2010;25:2447-59.
37. Cowan CM, Aghaloo T, Chou YF, Walder B, Zhang X, Soo C, et al. MicroCT evaluation of three-dimensional mineralization in response to BMP-2 doses in vitro and in critical sized rat calvarial defects. Tissue Eng. 2007;13:501-12.
38. Ionescu L, Byrne RN, van Haaften T, Vadivel A, Alphonse RS, Rey-Parra GJ, et al. Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action. Am J Physiol Lung Cell Mol Physiol. 2012;303:L967-977.
39. Zerbo IR, Zijderveld SA, De Boer A, Bronckers ALJJ, De Lange G, Bruggenkate CMT, et al. Histomorphometry of human sinus floor augmentation using a porous β-tricalcium phosphate: a prospective study. Clin Oral Implants Res. 2004;15:724-32.
40. Badylak SF, Valentin JE, Ravindra AK, McCabe GP, Stewart-Akers AM. Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Eng Part A. 2008;14:1835-42.